Provided by Tiger Fintech (Singapore) Pte. Ltd.

GlaxoSmithKline PLC

47.19
+1.082.34%
Post-market: 47.190.00000.00%19:58 EST
Volume:4.24M
Turnover:199.29M
Market Cap:95.78B
PE:13.21
High:47.32
Open:46.49
Low:46.47
Close:46.11
52wk High:48.69
52wk Low:31.72
Shares:2.03B
Float Shares:1.95B
Volume Ratio:0.82
T/O Rate:0.22%
Dividend:1.68
Dividend Rate:3.55%
EPS(TTM):3.57
EPS(LYR):1.58
ROE:41.52%
ROA:7.13%
PB:4.53
PE(LYR):29.84

Loading ...

Company Profile

Company Name:
GlaxoSmithKline PLC
Exchange:
NYSE
Establishment Date:
1715
Employees:
68629
Office Location:
79 New Oxford Street,London,Greater London,United Kingdom
Zip Code:
WC1A 1DG
Fax:
- -
Introduction:
GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.

Directors

Name
Position
Jonathan Symonds
Non-Executive Chairman
Luke Miels
Chief Commercial Officer, Chief Executive Officer, Director
Gavin Screaton
Non-Executive Director
Hal Barron
Non-Executive Director
Harry Dietz
Independent Non-Executive Director and Scientific & Medical Expert
Jeannie Lee
Independent Non-Executive Director and Scientific & Medical Expert
Jesse Goodman
Independent Non-Executive Director and Scientific & Medical Expert
Vishal Sikka
Independent Non-Executive Director
Wendy Becker
Independent Non-Executive Director

Shareholders

Name
Position
Luke Miels
Chief Commercial Officer, Chief Executive Officer, Director
Julie Brown
Chief Financial Officer
Harry Dietz
Independent Non-Executive Director and Scientific & Medical Expert
James Ford
SVP & Group General Counsel
Jeannie Lee
Independent Non-Executive Director and Scientific & Medical Expert
Jesse Goodman
Independent Non-Executive Director and Scientific & Medical Expert
Phil Thomson
President, Global Affairs
Regis Simard
President, Global Supply Chain
Sally Jackson
SVP, Global Communications and CEO Officer
Shobie Ramakrishnan
Chief Digital and Technology Officer
Tony Wood
Chief Scientific Officer